You have been chosen to receive this valuable information.

View in browser

Vertex cut weeks off build timelines with a risk-based approach to UAT

ACT
ACT

 

Hi %%First_name%%,

User Acceptance Testing (UAT) is the second most common cause of database build delays. Vertex Pharmaceuticals, Inc. changed its approach to UAT and cut weeks off their build timelines.

This free resource hub provides ways to ensure faster and higher quality UAT for EDC study builds. Learn how to:

  • Incorporate UAT earlier in the process to speed overall build times

  • Take a risk-based approach to UAT to save time and effort

  • Get real-time visibility to reduce delays and miscommunication

Access the resource hub here

ACT

Data Managers Telling Their Stories: Hear from industry leaders who drastically shortened build times with Agile Design share their experience.

ACT

UAT Agile Design Methods Unpacked: Learn how real-time design reviews secure user acceptance early in the build process.

ACT

On-Demand Demos: See how a Study Differential Report allows the data management team to spot differences between studies or study versions, including additions, omissions, and changes.

ACT

And More: Access video and blog resources detailing the advantages of a risk-based UAT process and how your organization can begin gleaning these benefits.

Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Applied Clinical Trials, an MJH Life Sciences™ brand. You are on the mailing list as %%emailaddress%%.
This email was sent by: %%Member_Busname%%
%%Member_Addr%%, %%Member_City%%, %%Member_State%%, %%Member_PostalCode%% %%Member_Country%%

Privacy Policy

Update Profile      Manage Subscriptions      Unsubscribe